IAJD34

IAJD-34 is a one-component ionizable amphiphilic Janus dendrimer specifically engineered for targeted mRNA delivery to the lung parenchyma, as described by Meshanni et al. in Nature Communications article "Targeted delivery of TGF-β mRNA to murine lung parenchyma using one-component ionizable amphiphilic Janus Dendrimers" . This synthetic nanoparticle self-assembles with mRNA through simple mixing in acetate buffer, forming stable dendrimersomes approximately 93-97 nm in size with high encapsulation efficiency (>95%) and a positive zeta potential (~48 mV) . Its defining feature, highlighted in the study, is exceptional lung tropism after intravenous injection, enabling significantly higher luciferase expression in murine lungs compared to other organs. As demonstrated by Meshanni et al., IAJD 34 effectively delivers therapeutic mRNA (e.g., TGF-β mRNA) to the lower lung, inducing transient protein production with minimal systemic toxicity at appropriate doses (e.g., 10 μg), offering a promising strategy for treating parenchymal lung diseases.

>98%

CCCCCCCCCCCOC1=CC (OCCCCCCCCCCC) =CC (CNC (=O) C2=CC (OCCOCCOCCOC (=O) CCCN3CCCCC3) =C (OCCOCCOCCOCC3=CC=CC=C3) C (OCCOCCOCCOC (=O) CCCN3CCCCC3) =C2) =C1

C79H129N3O17

1392.91